Does drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysis (Q28541480)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysis	scientific article

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Does drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysis (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Shilong Han

1

0 references

Xiaoping Zhang

2

0 references

Liling Zou

3

0 references

Chenhui Lu

4

0 references

Jun Zhang

5

0 references

Jue Li

6

0 references

Maoquan Li

7

0 references

language of work or name

0 references

publication date

2014

0 references

0 references

9

0 references

8

0 references

e102686

0 references

copyright license

Creative Commons Attribution 4.0 International

1 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

19 March 2017

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

7 April 2017

Current status of embolic agents for liver tumor embolization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Chemoembolization agents for cancer treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Hepatocellular carcinoma: latest developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

Bringing it all together: Lancet-Cochrane collaborate on systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

29 September 2017

New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

In vitro characterization of cisplatin-loaded superabsorbent polymer microspheres designed for chemoembolization

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Meta-analysis of heterogeneous clinical trials: an empirical example

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Midterm follow-up after DC-BEAD™-TACE of hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0102686

21 January 2018

Treatment of hepatocellular carcinoma using precision transcatheter arterial chemoembolization (TACE): results of two years' experience in a general hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4118844

27 November 2018

Transcatheter Arterial Chemoembolization with Epirubicin-Loaded Superabsorbent Polymer Microspheres for 135 Hepatocellular Carcinoma Patients: Single-Center Experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimization of doxorubicin loading for superabsorbent polymer microspheres: in vitro analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of diffuse hepatocellular carcinoma (≧ 10 Lesions) with doxorubicin-loaded DC beads is a safe and effective treatment option

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pharmacokinetics in patients treated with transarterial chemoembolization (TACE) using two types of epirubicin-loaded microspheres

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: initial tumour response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25083860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0102686

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2014PLoSO...9j2686H

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28541480&oldid=1949577552"